{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:44:14Z","timestamp":1785912254372,"version":"3.56.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20wm0125002"],"award-info":[{"award-number":["JP20wm0125002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP223fa627001"],"award-info":[{"award-number":["JP223fa627001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005612","name":"Shionogi and Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005612","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106350","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:10:52Z","timestamp":1782418252000},"page":"106350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effectiveness of baloxavir marboxil in nonhuman primates infected with highly pathogenic avian influenza A(H7N9) virus"],"prefix":"10.1016","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8266-020X","authenticated-orcid":false,"given":"Kiyoko","family":"Iwatsuki-Horimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3383-9980","authenticated-orcid":false,"given":"Toru","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Kiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsumi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Yasuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-5157","authenticated-orcid":false,"given":"Seiya","family":"Yamayoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5061-8296","authenticated-orcid":false,"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ebiom.2026.106350_bib1","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106350_bib2","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5582\/bst.2017.01040","article-title":"Global concern regarding the fifth epidemic of human infection with avian influenza A (H7N9) virus in China","volume":"11","author":"Shen","year":"2017","journal-title":"Biosci Trends"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106350_bib3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1473-3099(17)30323-7","article-title":"Epidemiology of avian influenza A H7N9 virus in human beings across five epidemics in mainland China, 2013\u201317: an epidemiological study of laboratory-confirmed case series","volume":"17","author":"Wang","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106350_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5365\/wpsar.2017.8.1.001","article-title":"Sudden increase in human infection with avian influenza A (H7N9) virus in China, September\u2013December 2016","volume":"8","author":"Zhou","year":"2017","journal-title":"West Pac Surveill Response J"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106350_bib5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.15585\/mmwr.mm6609e2","article-title":"Increase in human infections with avian influenza A(H7N9) virus during the fifth epidemic - china, October 2016-February 2017","volume":"66","author":"Iuliano","year":"2017","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106350_bib6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3201\/eid2308.170600","article-title":"Human infection with highly pathogenic avian influenza A(H7N9) virus, China","volume":"23","author":"Ke","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2026.106350_bib7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.15585\/mmwr.mm6635a2","article-title":"Update: increase in human infections with novel Asian lineage avian influenza A (H7N9) viruses during the fifth epidemic\u2014China, October 1, 2016\u2013August 7, 2017","volume":"66","author":"Kile","year":"2017","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106350_bib8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.tim.2017.06.008","article-title":"Epidemiology, evolution, and pathogenesis of H7N9 influenza viruses in five epidemic waves since 2013 in China","volume":"25","author":"Su","year":"2017","journal-title":"Trends Microbiol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106350_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jinf.2017.04.001","article-title":"Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China","volume":"75","author":"Zhang","year":"2017","journal-title":"J Infect"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106350_bib10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3201\/eid2308.170640","article-title":"Preliminary epidemiology of human infections with highly pathogenic avian influenza A (H7N9) virus, China, 2017","volume":"23","author":"Zhou","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106350_bib11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2019.01.005","article-title":"Comparison between human infections caused by highly and low pathogenic H7N9 avian influenza viruses in wave five: clinical and virological findings","volume":"78","author":"Yang","year":"2019","journal-title":"J Infect"},{"issue":"23","key":"10.1016\/j.ebiom.2026.106350_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01277-17","article-title":"Genesis and spread of newly emerged highly pathogenic H7N9 avian viruses in mainland China","volume":"91","author":"Yang","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2026.106350_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2018.08.001","article-title":"Repeated detection of H7N9 avian influenza viruses in raw poultry meat illegally brought to Japan by international flight passengers","volume":"524","author":"Shibata","year":"2018","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106350_bib14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/tbed.13398","article-title":"Characterization of H7N9 avian influenza viruses isolated from duck meat products","volume":"67","author":"Wu","year":"2020","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.ebiom.2026.106350_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.virol.2020.07.018","article-title":"Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016\u20132019","volume":"549","author":"Tang","year":"2020","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106350_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.chom.2017.09.008","article-title":"A highly pathogenic avian H7N9 influenza virus isolated from A human is lethal in some ferrets infected via respiratory droplets","volume":"22","author":"Imai","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2026.106350_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coviro.2019.01.006","article-title":"Baloxavir marboxil: the new influenza drug on the market","volume":"35","author":"O'Hanlon","year":"2019","journal-title":"Curr Opin Virol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106350_bib19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106350_bib20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","article-title":"Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial","volume":"20","author":"Ison","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106350_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00396-13","article-title":"Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R\/K viral population","volume":"4","author":"Yen","year":"2013","journal-title":"mBio"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106350_bib22","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3201\/eid1909.130724","article-title":"R292K substitution and drug susceptibility of influenza A(H7N9) viruses","volume":"19","author":"Sleeman","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106350_bib23","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1128\/JVI.03513-14","article-title":"Neuraminidase mutations conferring resistance to oseltamivir in influenza A(H7N9) viruses","volume":"89","author":"Marjuki","year":"2015","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106350_bib24","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1038\/s41598-018-27890-4","article-title":"Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil","volume":"8","author":"Omoto","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106350_bib25","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.3.1800698","article-title":"Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018","volume":"24","author":"Takashita","year":"2019","journal-title":"Euro Surveill"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106350_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01825-20","article-title":"Efficacy of a cap-dependent endonuclease inhibitor and neuraminidase inhibitors against H7N9 highly pathogenic Avian influenza virus causing severe viral pneumonia in cynomolgus macaques","volume":"65","author":"Suzuki","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106350_bib29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.chom.2014.11.002","article-title":"Influenza virus-host interactome screen as a platform for antiviral drug development","volume":"16","author":"Watanabe","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"16","key":"10.1016\/j.ebiom.2026.106350_bib30","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106350_bib31","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40265-018-0899-1","article-title":"Baloxavir: first global approval","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106350_bib32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/1060028019826565","article-title":"Baloxavir marboxil: the first cap-dependent endonuclease inhibitor for the treatment of influenza","volume":"53","author":"Yang","year":"2019","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106350_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/14740330902840519","article-title":"Oseltamivir for treatment and prophylaxis of influenza infection","volume":"8","author":"Schirmer","year":"2009","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106350_bib34","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1128\/AAC.00412-11","article-title":"Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques","volume":"55","author":"Kitano","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"7258","key":"10.1016\/j.ebiom.2026.106350_bib35","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nature08260","article-title":"In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses","volume":"460","author":"Itoh","year":"2009","journal-title":"Nature"},{"issue":"7468","key":"10.1016\/j.ebiom.2026.106350_bib36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature12392","article-title":"Characterization of H7N9 influenza A viruses isolated from humans","volume":"501","author":"Watanabe","year":"2013","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106350_bib37","doi-asserted-by":"crossref","first-page":"13195","DOI":"10.1128\/JVI.00859-11","article-title":"Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques","volume":"85","author":"Watanabe","year":"2011","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106350_bib38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/infdis\/jix296","article-title":"Emergence of oseltamivir-resistant H7N9 influenza viruses in immunosuppressed cynomolgus macaques","volume":"216","author":"Kiso","year":"2017","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106350_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00119-20","article-title":"Population pharmacokinetics and exposure-response relationships of baloxavir marboxil in influenza patients at high risk of complications","volume":"64","author":"Koshimichi","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106350_bib40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/jac\/dkaa393","article-title":"Pharmacokinetic and pharmacodynamic analysis of baloxavir marboxil, a novel cap-dependent endonuclease inhibitor, in a murine model of influenza virus infection","volume":"76","author":"Ando","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106350_bib41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/jac\/dky462","article-title":"Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection","volume":"74","author":"Fukao","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106350_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008395","article-title":"Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission","volume":"16","author":"Lee","year":"2020","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106350_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg007","article-title":"Early administration of oral oseltamivir increases the benefits of influenza treatment","volume":"51","author":"Aoki","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106350_bib44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/656408","article-title":"Early oseltamivir treatment of influenza in children 1-3 years of age: a randomized controlled trial","volume":"51","author":"Heinonen","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106350_bib45","first-page":"367","article-title":"Replicative fitness of seasonal influenza A viruses with decreased susceptibility to baloxavir","volume":"221","author":"Chesnokov","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106350_bib46","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/infdis\/jiz418","article-title":"Impact of the baloxavir-resistant polymerase acid I38T substitution on the fitness of contemporary influenza A(H1N1)pdm09 and A(H3N2) strains","volume":"221","author":"Checkmahomed","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106350_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41564-019-0609-0","article-title":"Influenza A variants with reduced susceptibility to baloxavir isolated from Japanese patients are fit and transmit through respiratory droplets","volume":"5","author":"Imai","year":"2020","journal-title":"Nat Microbiol"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106350_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a038687","article-title":"Influenza polymerase inhibitors: mechanisms of action and resistance","volume":"11","author":"Takashita","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106350_bib49","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.3.1800666","article-title":"Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016\/17 and 2017\/18 seasons","volume":"24","author":"Gubareva","year":"2019","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ebiom.2026.106350_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104718","article-title":"Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017-2018","volume":"175","author":"Takashita","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.ebiom.2026.106350_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105281","article-title":"Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018\u20132020","volume":"200","author":"Govorkova","year":"2022","journal-title":"Antivir Res"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:44:52Z","timestamp":1785908692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"alternative-id":["S2352396426002331"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106350","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of baloxavir marboxil in nonhuman primates infected with highly pathogenic avian influenza A(H7N9) virus","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106350"}}